Article citationsMore>>

US Food and Drug Administration (2015) Drug Safety Communication: FDA Warns That SGLT2 Inhibitors for Diabetes May Result a Serious Condition of Too Much Acid in Blood. 15 May 2015.

has been cited by the following article:

Contact us
Follow SCIRP
Twitter Facebook Linkedin Weibo
Free SCIRP Newsletters
Copyright © 2006-2021 Scientific Research Publishing Inc. All Rights Reserved.